Bee,
snake or scorpion venom could form the basis of a new generation of
cancer-fighting drugs, scientists find. They have developed a method for
targeting venom proteins specifically to malignant cells while sparing healthy
ones, which reduces or eliminates side effects that the toxins would otherwise cause.
Dipanjan
Pan from the University of
Illinois, who led the study, said that they had successfully
used venom toxins in tiny nanometer-sized particles to cure breast cancer and
melanoma cells in the laboratory.
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
Advertisement
"These particles, which are camouflaged from the immune system, take the toxin directly to the cancer cells, sparing normal tissue," Pan said.
Researchers
report that these venoms have proteins and peptides that, when separated from
the other components and tested individually, can attach to cancer cell
membranes. That activity could potentially block the growth and spread of the
disease.
![Pre-Cancerous Lesions]( "Pre-Cancerous Lesions")
Encyclopedia section of medindia gives general information about Pre Cancerous Lesions
The research team says that some of substances found in any of these venoms could be effective anti-tumor agents. However, just injecting venoms into a patient would have side effects. These effects include heart muscle or nerve cells, unwanted clotting or, alternately, bleeding under the skin.
The team set out to solve this problem. In the honeybee study, the team discovered a substance in the venom called melittin that keeps the cancer cells from multiplying.
Bees make so little venom that it's not possible to extract and separate out the substance time after time for lab testing or for later clinical use. That's why they synthesized melittin in the lab.
They carried out computational studies to figure out how melittin would work inside a nanoparticle. They did the test and injected their synthetic toxin into nanoparticles. They explain, "The peptide toxins we made are so tightly packed within the nanoparticle that they don't leach out when exposed to the bloodstream and cause side effects."
What they do is go directly to the tumor, where they bind to cancer stem cells, blocking their growth and spread. According to the team, the next step is to examine the new treatment approach in rats and pigs. Eventually, they hope to begin a study involving patients. He estimates that this should be in the next three to five years.
Source: Medindia
Pre-Cancerous Lesions
Encyclopedia section of medindia gives general information about Pre Cancerous Lesions
Advertisement
The research team says that some of substances found in any of these venoms could be effective anti-tumor agents. However, just injecting venoms into a patient would have side effects. These effects include heart muscle or nerve cells, unwanted clotting or, alternately, bleeding under the skin.
The team set out to solve this problem. In the honeybee study, the team discovered a substance in the venom called melittin that keeps the cancer cells from multiplying.
Bees make so little venom that it's not possible to extract and separate out the substance time after time for lab testing or for later clinical use. That's why they synthesized melittin in the lab.
They carried out computational studies to figure out how melittin would work inside a nanoparticle. They did the test and injected their synthetic toxin into nanoparticles. They explain, "The peptide toxins we made are so tightly packed within the nanoparticle that they don't leach out when exposed to the bloodstream and cause side effects."
What they do is go directly to the tumor, where they bind to cancer stem cells, blocking their growth and spread. According to the team, the next step is to examine the new treatment approach in rats and pigs. Eventually, they hope to begin a study involving patients. He estimates that this should be in the next three to five years.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Malaria parasites sync their molecular rhythms with the internal 24-hour clocks of their hosts, said researchers.
A latest research suggests that the quality of a person's post-work recovery in the evening can impact their mood when they resume work the next day.
Researchers are working on new strategies and solutions for sleep apnea to ward off a range of health risks including cognitive decline.
The scientists discovered that when the stem cells in the hair follicle are made softer, they have a higher chance of growing hair.
A combinatorial therapy provided promising beneficial results among people with ischemic stroke.